Crossmark

How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?

Crossref DOI link: https://doi.org/10.1007/s00261-020-02771-5

Published Online: 2020-09-19

Published Print: 2021-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zaki, Islam H.

Shropshire, Erin

Zhang, Shuaiqi

Xiao, Dong

Wildman-Tobriner, Benjamin

Marin, Daniele

Gupta, Rajan T.

Erkanli, Alaattin

Nelson, Redon C.

Bashir, Mustafa R.
License Information

Text and Data Mining valid from 2020-09-19

Version of Record valid from 2020-09-19
More Information

Article History

Received: 11 June 2020

Revised: 1 September 2020

Accepted: 10 September 2020

First Online: 19 September 2020

Compliance with ethical standards

:

: The authors declare that there is no conflict of interest.

Document is current

Any future updates will be listed below